These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28178665)

  • 21. Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis.
    Wu SW; Ma CC; Li WH
    Diagn Pathol; 2015 Aug; 10():144. PubMed ID: 26276145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors.
    Higashi T; Tamaki N; Torizuka T; Nakamoto Y; Sakahara H; Kimura T; Honda T; Inokuma T; Katsushima S; Ohshio G; Imamura M; Konishi J
    J Nucl Med; 1998 Oct; 39(10):1727-35. PubMed ID: 9776278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic implications of glucose transporter protein-1 (glut-1) overexpression in bone and soft-tissue sarcomas.
    Endo M; Tateishi U; Seki K; Yamaguchi U; Nakatani F; Kawai A; Chuman H; Beppu Y
    Jpn J Clin Oncol; 2007 Dec; 37(12):955-60. PubMed ID: 18211986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic role of HER2 amplification based on fluorescence in situ hybridization (FISH) in pancreatic ductal adenocarcinoma (PDAC): a meta-analysis.
    Li X; Zhao H; Gu J; Zheng L
    World J Surg Oncol; 2016 Feb; 14(1):38. PubMed ID: 26897036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between GLUT-1 and vascular endothelial growth factor expression and 18F-FDG uptake in esophageal squamous cell cancer patients.
    Kobayashi M; Kaida H; Kawahara A; Hattori S; Kurata S; Hayakawa M; Hirose Y; Uchida M; Kage M; Fujita H; Hayabuchi N; Ishibashi M
    Clin Nucl Med; 2012 May; 37(5):447-52. PubMed ID: 22475893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma.
    Bachet JB; Maréchal R; Demetter P; Bonnetain F; Cros J; Svrcek M; Bardier-Dupas A; Hammel P; Sauvanet A; Louvet C; Paye F; Vaillant JC; André T; Closset J; Salmon I; Emile JF; Van Laethem JL
    Eur J Cancer; 2013 Aug; 49(12):2643-53. PubMed ID: 23726265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer.
    Wang P; Fan J; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Xu ZD; Liu LM
    Ann Surg Oncol; 2009 Apr; 16(4):826-35. PubMed ID: 19165547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of Muc5AC in gastric cancer: A meta-analysis.
    Zhang CT; He KC; Pan F; Li Y; Wu J
    World J Gastroenterol; 2015 Sep; 21(36):10453-60. PubMed ID: 26420972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
    Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH
    Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
    Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
    Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic and clinicopathological significance of systemic immune-inflammation index in pancreatic cancer: a meta-analysis of 2,365 patients.
    Shui Y; Li M; Su J; Chen M; Gu X; Guo W
    Aging (Albany NY); 2021 Aug; 13(16):20585-20597. PubMed ID: 34435973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of B7-H4 in pancreatic cancer: Systematic review and meta-analysis.
    Chen X; Tao L; Yuan C; Xiu D
    Medicine (Baltimore); 2018 Mar; 97(12):e0088. PubMed ID: 29561406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of PODXL/ITGB1 and BCL7B/ITGB1 accurately predicts unfavorable prognosis compared to the TNM staging system in postoperative pancreatic cancer patients.
    Taniuchi K; Furihata M; Naganuma S; Sakaguchi M; Saibara T
    PLoS One; 2019; 14(6):e0217920. PubMed ID: 31166991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
    Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
    BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
    Osugi J; Yamaura T; Muto S; Okabe N; Matsumura Y; Hoshino M; Higuchi M; Suzuki H; Gotoh M
    Lung Cancer; 2015 Jun; 88(3):310-8. PubMed ID: 25837797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression profile and prognostic value of NNMT in patients with pancreatic cancer.
    Xu Y; Liu P; Zheng DH; Wu N; Zhu L; Xing C; Zhu J
    Oncotarget; 2016 Apr; 7(15):19975-81. PubMed ID: 26942567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA CCAT2 can predict metastasis and poor prognosis: A meta-analysis.
    Fan YH; Fang H; Ji CX; Xie H; Xiao B; Zhu XG
    Clin Chim Acta; 2017 Mar; 466():120-126. PubMed ID: 28089750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of glucose transporter-1 and glucose transporter-3 for survival of cancer patients: A meta-analysis.
    Chen X; Lu P; Zhou S; Zhang L; Zhao JH; Tang JH
    Oncotarget; 2017 Feb; 8(8):13206-13213. PubMed ID: 28086215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer.
    Sierzega M; Popiela T; Kulig J; Nowak K
    Pancreas; 2006 Oct; 33(3):240-5. PubMed ID: 17003644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.